[1]BioorganicandMedicinalChemistryLetters,2011,vol.21,#18,p.5605-5609
[2]ACSMedicinalChemistryLetters,2013,vol.4,#11,p.1102-1107
[3]JournalofMedicinalChemistry,2013,vol.56,#18,p.7190-7200
[1]BioorganicandMedicinalChemistryLetters,2011,vol.21,#18,p.5605-5609
[2]JournalofMedicinalChemistry,2013,vol.56,#18,p.7190-7200
[3]ACSMedicinalChemistryLetters,2013,vol.4,#11,p.1102-1107
[1]BioorganicandMedicinalChemistryLetters,2011,vol.21,#18,p.5605-5609
[2]JournalofMedicinalChemistry,2013,vol.56,#18,p.7190-7200
[3]ACSMedicinalChemistryLetters,2013,vol.4,#11,p.1102-1107
[1]BioorganicandMedicinalChemistryLetters,2011,vol.21,#18,p.5605-5609
[2]ACSMedicinalChemistryLetters,2013,vol.4,#11,p.1102-1107
[1]ACSMedicinalChemistryLetters,2013,vol.4,#11,p.1102-1107
Title: Zhang X, et al. Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9623-8.
Title: De Simone V, et al. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene. 2015 Jul;34(27):3493-503.